Pfizer
PFE
PFE
1,872 hedge funds and large institutions have $155B invested in Pfizer in 2015 Q1 according to their latest regulatory filings, with 120 funds opening new positions, 712 increasing their positions, 817 reducing their positions, and 86 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,872
Holders Change
+14
Holders Change %
+0.75%
% of All Funds
49.93%
Holding in Top 10
308
Holding in Top 10 Change
+83
Holding in Top 10 Change %
+36.89%
% of All Funds
8.22%
New
120
Increased
712
Reduced
817
Closed
86
Calls
$2.39B
Puts
$1.7B
Net Calls
+$691M
Net Calls Change
+$504M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$1.67B |
| 2 |
JPMorgan Chase & Co
New York
|
+$955M |
| 3 |
Goldman Sachs
New York
|
+$714M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$351M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$330M |
Top Sellers
| 1 |
IC
Institutional Capital
Chicago,
Illinois
|
-$282M |
| 2 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
-$267M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$256M |
| 4 |
D.E. Shaw & Co
New York
|
-$241M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$224M |
